(Q36410590)

14 August 2017

1 reference

title

Homocysteine: role and implications in atherosclerosis (English)

1 reference

14 August 2017

1 reference

William G Haynes

2

0 references

author name string

Sasidhar Guthikonda

series ordinal

1

1 reference

14 August 2017

language of work or name

1 reference

1 March 2006

1 reference

Current Atherosclerosis Reports

14 August 2017

published in

1 reference

14 August 2017

volume

8

1 reference

14 August 2017

issue

2

1 reference

14 August 2017

page(s)

100-106

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-006-0046-4

14 August 2017

exact match

0 references

cites work

Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease

1 reference

https://api.crossref.org/works/10.1007%2FS11883-006-0046-4

High homocysteine levels are independently related to isolated systolic hypertension in older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-006-0046-4

Total homocyst(e)ine concentration and the likelihood of nonfatal stroke: results from the Third National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-006-0046-4

Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-006-0046-4

Treatment of hyperhomocysteinemia in renal transplant recipients. A randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-006-0046-4

Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-006-0046-4

Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial

21 January 2018

1 reference

12 December 2020

Effect of homocysteine and homocystine on platelet and vascular arachidonic acid metabolism

1 reference

12 December 2020

The effect of folic acid fortification on plasma folate and total homocysteine concentrations

1 reference

12 December 2020

Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction

1 reference

12 December 2020

Effect of low doses of 5-methyltetrahydrofolate and folic acid on plasma homocysteine in healthy subjects with or without the 677C-->T polymorphism of methylenetetrahydrofolate reductase

1 reference

12 December 2020

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

1 reference

12 December 2020

Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia

1 reference

12 December 2020

Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine

1 reference

12 December 2020

Plasma homocysteine levels and mortality in patients with coronary artery disease

1 reference

12 December 2020

Hyperhomocysteinemia-induced vascular damage in the minipig. Captopril-hydrochlorothiazide combination prevents elastic alterations

1 reference

12 December 2020

Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis

1 reference

12 December 2020

Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans

1 reference

12 December 2020

Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease

1 reference

12 December 2020

Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial

1 reference

12 December 2020

Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen

1 reference

12 December 2020

Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Homocysteine Lowering Trialists' Collaboration

1 reference

12 December 2020

Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine

1 reference

12 December 2020

Tissue plasminogen activator binding to the annexin II tail domain. Direct modulation by homocysteine

1 reference

12 December 2020

Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis

1 reference

12 December 2020

The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells

1 reference

12 December 2020

Hyperhomocysteinemia increases intimal hyperplasia in a rat carotid endarterectomy model.

1 reference

12 December 2020

Randomized trial of folic acid supplementation and serum homocysteine levels

1 reference

12 December 2020

Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial.

1 reference

12 December 2020

Decreased rate of coronary restenosis after lowering of plasma homocysteine levels

1 reference

12 December 2020

Lack of association between plasma homocysteine and angiographic coronary artery disease in the era of fortification of cereal grain flour with folic acid.

1 reference

12 December 2020

Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells

1 reference

12 December 2020

Vitamin status and intake as primary determinants of homocysteinemia in an elderly population

1 reference

12 December 2020

Serum homocysteine in relation to mortality and morbidity from coronary heart disease: a 24-year follow-up of the population study of women in Gothenburg

1 reference

12 December 2020

Effect of consumption of red wine, spirits, and beer on serum homocysteine

1 reference

12 December 2020

Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis.

1 reference

12 December 2020

Dose-dependent effects of folic acid on plasma homocysteine in a randomized trial conducted among 723 individuals with coronary heart disease

1 reference

12 December 2020

Plasma concentrations of homocysteine and other aminothiol compounds are related to food intake in healthy human subjects.

1 reference

12 December 2020

Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death

1 reference

12 December 2020

Homocysteine enhances neutrophil-endothelial interactions in both cultured human cells and rats In vivo

1 reference

12 December 2020

Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

1 reference

12 December 2020

Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study.

1 reference

12 December 2020

Serum total homocysteine concentrations in adolescent and adult Americans: results from the third National Health and Nutrition Examination Survey.

1 reference

12 December 2020

Betaine Supplementation Lowers Plasma Homocysteine in Healthy Men and Women

1 reference

12 December 2020

A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians

1 reference

12 December 2020

Vitamins and progression of atherosclerosis in hyper-homocyst(e)inaemia

1 reference

12 December 2020

Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model

1 reference

12 December 2020

Evidence of carotid artery wall hypertrophy in homozygous homocystinuria

1 reference

12 December 2020

Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial

1 reference

12 December 2020

10.1007/S11883-006-0046-4

Identifiers

DOI

1 reference

14 August 2017

1 reference